UK markets open in 1 hour 20 minutes

Unilever PLC (ULVR.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
3,662.00-274.50 (-6.97%)
At close: 05:15PM GMT
Full screen
Previous close3,936.50
Bid3,682.50 x 0
Ask3,684.00 x 0
Day's range3,602.00 - 3,788.50
52-week range3,602.00 - 4,924.00
Avg. volume3,940,435
Market cap93.977B
Beta (5Y monthly)0.17
PE ratio (TTM)21.30
EPS (TTM)171.90
Earnings date10 Feb 2022
Forward dividend & yield1.44 (3.66%)
Ex-dividend date04 Nov 2021
1y target est53.04
  • The Guardian

    Unilever’s bid for GSK consumables isn’t quite the shocker it seems

    This could be a long campaign and, despite all the difficulties, there is a logic to the proposal

  • The Telegraph

    Glaxo courts Qatar and Singapore to head off £50bn Unilever swoop

    GlaxoSmithKline is courting the sovereign wealth funds of Qatar and Singapore as cornerstone investors in a listing of its £50bn consumer business as it seeks to head off a risky takeover by Unilever.

  • Reuters

    Unilever's offer for GSK's consumer health raises doubts, questions over strategy

    Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected -- should it raise the bid and risk overpaying or seek another route to expand in healthcare? The bid for GSK's assets, including Sensodyne toothpaste and Advil painkillers, comes as Unilever is dealing with steep inflation and sluggish growth in emerging markets, where it derives 60% of its revenues. Analysts said digesting GSK's consumer health assets at a price of over 50 billion pounds in cash and stock, would nearly triple Unilever's leverage towards 5.6 times in the first year from 2 times net debt to EBITDA currently.